Timothy Brady
Gastroenterology · St Louis, MONPI 1518056258
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,791 and has fallen 95.5% since, to $81 in 2025.
Across 181 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$676
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$466
- Takeda Pharmaceuticals U.S.A., Inc.$297
- Johnson & Johnson$253
- Pfizer$251
- Gilead$250
- plus $870 from 16 others
Across 2 payments — averaging $4745.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ironwood Pharmaceuticals, Inc$9K
What the payments were for
- Food & beverage$2,96397%
- Education$993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $676 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 25 | $466 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $297 |
| Johnson & Johnson | 11 | $253 |
| Pfizer | 18 | $251 |
| Gilead | 14 | $250 |
| Dova Pharmaceuticals | 4 | $141 |
| UCB, Inc. | 8 | $138 |
| Ironwood Pharmaceuticals, Inc | 8 | $123 |
| Stryker | 4 | $122 |
| Abbott | 4 | $81 |
| Daiichi Sankyo Inc. | 3 | $44 |
| Amgen | 2 | $33 |
| Redhill Biopharma Inc. | 2 | $31 |
| Braintree Laboratories, Inc. | 2 | $27 |
| Alfasigma USA, Inc. | 1 | $22 |
| Boston Scientific | 1 | $22 |
| Romark Laboratories, LC | 1 | $21 |
| Merck | 1 | $20 |
| Concordia Pharmaceuticals Inc. | 1 | $19 |
| QOL Medical, LLC | 3 | $15 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,062 in reported general payments places this provider in the 60th percentile of 374 gastroenterology providers in Missouri.
Other gastroenterology in St Louis
- Gregory SayukSaint Louis$1.1M
- Katie SchroederSaint Louis$730K
- David AlpersSaint Louis$616K
- Kamran QureshiLake St Louis$279K
- Laith Al MomaniKansas City$249K
- Ahmed SaeedKansas City$246K
- Parakkal DeepakSaint Louis$205K
- Bradley AndersonColumbia$194K
- Mauricio Lisker MelmanSaint Louis$179K
- Matthew CiorbaSaint Louis$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.